Bifidobacterium bifidum was isolated from adult intestine. It is an essential bacteria found in the human intestine.
For Research Use Only. Not intended for use in food manufacturing or medical procedures (diagnostics or therapeutics). Do Not Use in Humans.
CAT | Size | Price | Quantity | |
---|---|---|---|---|
LBST-051FG |
|
Product Information | |
---|---|
Product Overview | Bifidobacterium bifidum was isolated from adult intestine. It is an essential bacteria found in the human intestine. |
Target | Bifidobacterium |
Genus | Bifidobacterium |
Application | Study and research |
Type Strain | No |
Culture Medium | BBL |
Culture Conditions | 37°C; Anaerobic |
Source | Adult intestine |
Risk Group | 1 |
Product Format | Freeze-dried |
Packaging | Ampoule tube |
Storage | -80°C |
Shelf Life | 6 years |
Target Introduction | |
---|---|
Introduction | Bifidobacterium are Gram-positive, heterofermentative, anaerobic bacteria with a distinctive bifid; i.e. Y shape after which they are named. They are originally isolated from the faeces of breast-fed infants, members of the genus Bifidobacterium are commonly found in the GI tract of mammals. In humans, Bifidobacterium resides within the GI tract, from birth to old age. Disturbances in the microbiota are linked to an ever-growing number of immune-linked disease states including IBD, atopic allergy, arthritis, and obesity. Therefore, there is a significant interest in treating these diseases through microbial or "probiotic" supplementation of patients, including Bifidobacterium. Data from mouse models and clinical trials indicate that Bifidobacterium may have beneficial effects for treating and preventing immune-linked diseases, including gut-associated and systemic conditions. Bifidobacterium have been commercially exploited as probiotic agents due to their associated health benefits and GRAS; Generally Recognised As Safe status. |
Alternative Names | Bifidobacterium bifidum; 20215 |
Bifidobacterium bifidum is valued for its potential health benefits, including probiotic effects on gut microbiota balance and immune system modulation. Researchers utilize it to study its impact on digestive health and microbial interactions.
Start by thawing frozen stocks gently and inoculating them into fresh growth medium suitable for Bifidobacterium species. Incubate under anaerobic conditions at a controlled temperature (typically 37°C) to maintain viability and purity throughout experiments.
Use viability assays such as CFU counting on selective media or metabolic activity tests like SCFA production assays. Additionally, molecular techniques such as qPCR can quantify Bifidobacterium bifidum DNA/RNA levels in complex biological samples.
Yes, researchers often combine Bifidobacterium bifidum with other probiotic strains or prebiotic substrates to enhance its beneficial effects on gut health. Investigate synergistic interactions through co-culture studies and metabolic profiling to optimize therapeutic outcomes.
Prioritize animal models with relevant physiological similarities to humans, ensuring proper ethical approvals and compliance with animal welfare guidelines. Monitor host responses and gut microbiota dynamics using non-invasive techniques to validate therapeutic efficacy.
Click the button below to contact us or submit your feedback about this product.
For Research Use Only. Not intended for use in food manufacturing or medical procedures (diagnostics or therapeutics). Do Not Use in Humans.
Copyright © 2024 Creative Biolabs. All Rights Reserved.